These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2187 related articles for article (PubMed ID: 20537493)

  • 21. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
    Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
    J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of fractional flow reserve in patients with multi-vessel coronary artery disease and borderline lesions prevents unnecessary revascularisation procedures.
    Reczuch K; Jankowska E; Telichowski A; Porada A; Banasiak W; Ponikowski P
    Kardiol Pol; 2004 Apr; 60(4):311-19; discussion 320-1. PubMed ID: 15226780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.
    Hannan EL; Wu C; Walford G; Culliford AT; Gold JP; Smith CR; Higgins RS; Carlson RE; Jones RH
    N Engl J Med; 2008 Jan; 358(4):331-41. PubMed ID: 18216353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.
    De Bruyne B; Pijls NH; Kalesan B; Barbato E; Tonino PA; Piroth Z; Jagic N; Möbius-Winkler S; Rioufol G; Witt N; Kala P; MacCarthy P; Engström T; Oldroyd KG; Mavromatis K; Manoharan G; Verlee P; Frobert O; Curzen N; Johnson JB; Jüni P; Fearon WF;
    N Engl J Med; 2012 Sep; 367(11):991-1001. PubMed ID: 22924638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction.
    Corpus RA; House JA; Marso SP; Grantham JA; Huber KC; Laster SB; Johnson WL; Daniels WC; Barth CW; Giorgi LV; Rutherford BD
    Am Heart J; 2004 Sep; 148(3):493-500. PubMed ID: 15389238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of combined intracoronary pressure and blood flow velocity measurements after deferral of percutaneous coronary intervention.
    Meuwissen M; Chamuleau SA; Siebes M; de Winter RJ; Koch KT; Dijksman LM; van den Berg AJ; Tijssen JG; Spaan JA; Piek JJ
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):291-7. PubMed ID: 18288725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fame comes at a cost: a Canadian analysis of procedural costs in use of pressure wire to guide multivessel percutaneous coronary intervention.
    Hoole SP; Seddon MD; Poulter RS; Mancini GB; Wood DA; Saw J
    Can J Cardiol; 2011; 27(2):262.e1-2. PubMed ID: 21459275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial.
    Lee JM; Kim HK; Park KH; Choo EH; Kim CJ; Lee SH; Kim MC; Hong YJ; Ahn SG; Doh JH; Lee SY; Park SD; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Koo BK; Lee BK; Yun KH; Hong D; Joh HS; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Hahn JY;
    Eur Heart J; 2023 Feb; 44(6):473-484. PubMed ID: 36540034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison.
    Ijsselmuiden AJ; Ezechiels J; Westendorp IC; Tijssen JG; Kiemeneij F; Slagboom T; van der Wieken R; Tangelder G; Serruys PW; Laarman G
    Am Heart J; 2004 Sep; 148(3):467-74. PubMed ID: 15389234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractional flow reserve guided coronary revascularization in drug-eluting era in Thai patients with borderline multi-vessel coronary stenoses.
    Angkananard T; Wongpraparut N; Tresukosol D; Panchavinin P
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S25-32. PubMed ID: 21721425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation).
    Fearon WF; Nishi T; De Bruyne B; Boothroyd DB; Barbato E; Tonino P; Jüni P; Pijls NHJ; Hlatky MA;
    Circulation; 2018 Jan; 137(5):480-487. PubMed ID: 29097450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multivessel coronary drug-eluting stenting alone in patients with significant ischemic mitral regurgitation: a 4-year follow up.
    Ho PC; Nguyen ME
    J Invasive Cardiol; 2008 Jan; 20(1):41-3. PubMed ID: 18174619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of percutaneous coronary intervention in intermediate coronary artery disease: fractional flow reserve-guided versus intravascular ultrasound-guided.
    Nam CW; Yoon HJ; Cho YK; Park HS; Kim H; Hur SH; Kim YN; Chung IS; Koo BK; Tahk SJ; Fearon WF; Kim KB
    JACC Cardiovasc Interv; 2010 Aug; 3(8):812-7. PubMed ID: 20723852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Improvement in Fractional Flow Reserve With Outcomes, Including Symptomatic Relief, After Percutaneous Coronary Intervention.
    Fournier S; Ciccarelli G; Toth GG; Milkas A; Xaplanteris P; Tonino PAL; Fearon WF; Pijls NHJ; Barbato E; De Bruyne B
    JAMA Cardiol; 2019 Apr; 4(4):370-374. PubMed ID: 30840026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractional flow reserve-guided PCI for stable coronary artery disease.
    De Bruyne B; Fearon WF; Pijls NH; Barbato E; Tonino P; Piroth Z; Jagic N; Mobius-Winckler S; Rioufol G; Witt N; Kala P; MacCarthy P; Engström T; Oldroyd K; Mavromatis K; Manoharan G; Verlee P; Frobert O; Curzen N; Johnson JB; Limacher A; Nüesch E; Jüni P;
    N Engl J Med; 2014 Sep; 371(13):1208-17. PubMed ID: 25176289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should we be using fractional flow reserve more routinely to select stable coronary patients for percutaneous coronary intervention?
    Park SJ; Ahn JM
    Curr Opin Cardiol; 2012 Nov; 27(6):675-81. PubMed ID: 23044917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anatomical and physiologic assessments in patients with small coronary artery disease: final results of the Physiologic and Anatomical Evaluation Prior to and After Stent Implantation in Small Coronary Vessels (PHANTOM) trial.
    Costa MA; Sabate M; Staico R; Alfonso F; Seixas AC; Albertal M; Crossman A; Angiolillo DJ; Zenni M; Sousa JE; Macaya C; Bass TA
    Am Heart J; 2007 Feb; 153(2):296.e1-7. PubMed ID: 17239692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 110.